Physician
Calvary Medical, PA
Calvary Medical, PA was paid $11.05M by Medicaid between Jan 2018 and Dec 2024, across 176 billing codes. Its largest line is 99213, doctor's office visit, returning patient (routine) — 19% of everything it billed.
33Billing provider infoCALVARY MEDICAL, PA
CLEVELAND, TX 77327
CLEVELAND, TX 77327
33aNPI1265568042assigned 02/26/2007
33bProvider typeFamily Medicine Physician
28Total paid$11.05M
24GClaims473,537
24DCodes billed176
24AFirst – last monthJan 2018 – Dec 2024
Compared with peers
Next to other Family Medicine Physician providers in Texas
Rank by total paid#3 of 1,204
Median peer was paid$31K
This provider vs. median359×
Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.
Box 24A · Dates of service
Paid by month
Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider
By year, as a table
| Year | Claims | Paid | |
|---|---|---|---|
| 2018 | 6,769 | $106K | |
| 2019 | 8,657 | $146K | |
| 2020 | 56,801 | $1.03M | |
| 2021 | 102,229 | $2.12M | |
| 2022 | 104,536 | $2.73M | |
| 2023 | 107,666 | $2.92M | |
| 2024incomplete | 86,879 | $2.00M |
Box 24 · Service lines
What it billed for
| Code | Service | Share | Claims | Bene. records | Paid |
|---|---|---|---|---|---|
| 99213 | Doctor's office visit, returning patient (routine)Office or other outpatient visit for the evaluation and management of an established patient, low complexity | 19% | 56,841 | 50,332 | $2.05M |
| 99214 | Doctor's office visit, returning patient (more involved)Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity | 14% | 31,150 | 28,800 | $1.54M |
| 95165 | Professional services for the supervision of preparation and provision of antigens for allergen immunotherapy, multiple dose vials | 13% | 7,038 | 967 | $1.42M |
| 99393 | Periodic comprehensive preventive medicine reevaluation, established patient, late childhood (5-11 years) | 5.9% | 7,519 | 7,377 | $655K |
| 99392 | Periodic comprehensive preventive medicine reevaluation, established patient, early childhood (1-4 years) | 5.6% | 7,502 | 7,379 | $617K |
| 99394 | Periodic comprehensive preventive medicine reevaluation, established patient, adolescent (12-17 years) | 5.5% | 6,405 | 6,273 | $606K |
| 99391 | Periodic comprehensive preventive medicine reevaluation, established patient, infant (under 1 year) | 4.5% | 6,411 | 5,963 | $497K |
| 90460 | Immunization administration through 18 years of age via any route, first or only component | 3.5% | 36,492 | 15,664 | $382K |
| 95004 | Percutaneous tests with allergenic extracts, immediate type reaction | 3.0% | 1,053 | 1,006 | $330K |
| 87635 | Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe | 2.8% | 6,182 | 5,792 | $305K |
| 87428 | 2.2% | 6,464 | 6,057 | $239K | |
| 99091 | 2.1% | 1,513 | 1,486 | $233K |
164 more codes
| S8301 | Infection control supplies, not otherwise specified | 1.6% | 13,799 | $182K |
| 99395 | Periodic comprehensive preventive medicine reevaluation, established patient, 18-39 years | 1.6% | 2,529 | $176K |
| 99203 | Doctor's office visit, new patient (routine) | 1.2% | 2,367 | $133K |
| 99429 | 1.1% | 3,563 | $121K | |
| 99444 | <1% | 1,917 | $108K | |
| 99381 | <1% | 1,275 | $97K | |
| 87880 | Infectious agent antigen detection by immunoassay; Streptococcus, group A | <1% | 6,309 | $83K |
| 99211 | Office or other outpatient visit for the evaluation and management of an established patient, minimal severity | <1% | 8,056 | $77K |
| 99396 | Periodic comprehensive preventive medicine reevaluation, established patient, 40-64 years | <1% | 1,253 | $77K |
| 96110 | Developmental screening, with scoring and documentation, per standardized instrument | <1% | 9,098 | $76K |
| H0049 | Alcohol and/or drug screening | <1% | 6,202 | $72K |
| 95923 | <1% | 972 | $68K | |
| 99423 | <1% | 1,139 | $64K | |
| 87804 | Infectious agent antigen detection by immunoassay; Influenza, each type | <1% | 4,828 | $63K |
| 87426 | Infectious agent antigen detection, SARS-CoV-2 (COVID-19) | <1% | 851 | $63K |
| 90461 | <1% | 7,385 | $59K | |
| 99204 | Doctor's office visit, new patient (more involved) | <1% | 609 | $48K |
| 95921 | <1% | 971 | $47K | |
| 99383 | <1% | 470 | $45K | |
| 87651 | Infectious agent detection by nucleic acid; Streptococcus, group A, amplified probe | <1% | 1,729 | $44K |
| 99385 | <1% | 547 | $43K | |
| 93923 | <1% | 2,022 | $39K | |
| 99000 | <1% | 4,352 | $38K | |
| 99384 | <1% | 340 | $35K | |
| 99212 | Office or other outpatient visit for the evaluation and management of an established patient, straightforward | <1% | 1,196 | $30K |
| G8510 | Screening for depression is documented as negative, a follow-up plan is not required | <1% | 6,887 | $24K |
| 95117 | <1% | 2,685 | $20K | |
| 80305 | <1% | 1,905 | $18K | |
| 83036 | Hemoglobin; glycosylated (A1C) | <1% | 2,788 | $17K |
| 99202 | Office or other outpatient visit for the evaluation and management of a new patient, straightforward | <1% | 401 | $16K |
| 96372 | Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular | <1% | 1,544 | $16K |
| 97169 | <1% | 687 | $15K | |
| 99382 | <1% | 128 | $12K | |
| 90674 | <1% | 400 | $11K | |
| 90677 | <1% | 560 | $9K | |
| 99460 | <1% | 113 | $8K | |
| G8431 | Screening for depression is documented as being positive and a follow-up plan is documented | <1% | 3,256 | $7K |
| 81025 | <1% | 1,099 | $7K | |
| CP001 | <1% | 744 | $7K | |
| 81003 | <1% | 4,044 | $7K | |
| 99490 | Ccm add 20min | <1% | 2,099 | $7K |
| 99215 | Doctor's office visit, returning patient (complex) | <1% | 98 | $6K |
| 54150 | <1% | 77 | $6K | |
| 96160 | <1% | 3,793 | $6K | |
| 99238 | Hospital discharge day management, 30 minutes or less | <1% | 102 | $6K |
| 83655 | <1% | 568 | $5K | |
| 87502 | Infectious agent detection by nucleic acid, influenza virus, for multiple types or subtypes, includes all targets | <1% | 80 | $5K |
| 99406 | <1% | 799 | $4K | |
| 92250 | <1% | 65 | $3K | |
| 87899 | <1% | 280 | $3K | |
| 95115 | <1% | 492 | $3K | |
| 94760 | <1% | 12,868 | $2K | |
| 90686 | <1% | 2,633 | $2K | |
| 82044 | <1% | 557 | $2K | |
| 90471 | Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections), 1 vaccine | <1% | 306 | $2K |
| 99386 | <1% | 28 | $2K | |
| 90651 | <1% | 1,726 | $2K | |
| 93000 | <1% | 157 | $2K | |
| 87807 | <1% | 179 | $2K | |
| 90734 | <1% | 2,758 | $2K | |
| 99457 | <1% | 1,466 | $2K | |
| 99408 | <1% | 78 | $1K | |
| 87420 | <1% | 112 | $1K | |
| 99454 | <1% | 656 | $1K | |
| 99050 | <1% | 57 | $924.59 | |
| 90670 | <1% | 4,043 | $813.45 | |
| 3044F | <1% | 1,093 | $580.04 | |
| 84443 | Thyroid stimulating hormone (TSH) | <1% | 168 | $577.00 |
| G0447 | Face-to-face behavioral counseling for obesity, 15 minutes | <1% | 17,406 | $568.64 |
| 99458 | <1% | 645 | $537.03 | |
| 90715 | <1% | 1,582 | $525.97 | |
| 99462 | <1% | 14 | $506.68 | |
| A4556 | Electrodes, (e.g., apnea monitor), per pair | <1% | 157 | $482.43 |
| 93925 | <1% | 24 | $418.20 | |
| 92587 | <1% | 102 | $410.55 | |
| 83013 | <1% | 14 | $395.64 | |
| CP002 | <1% | 42 | $390.04 | |
| 90688 | <1% | 338 | $374.46 | |
| 85027 | <1% | 297 | $355.77 | |
| 80053 | Comprehensive metabolic panel | <1% | 213 | $327.79 |
| 84481 | <1% | 109 | $302.57 | |
| 82043 | <1% | 78 | $265.40 | |
| 98960 | <1% | 31 | $234.42 | |
| 84439 | <1% | 155 | $229.61 | |
| 90671 | <1% | 625 | $223.30 | |
| 90620 | <1% | 103 | $192.49 | |
| 83735 | <1% | 217 | $179.89 | |
| 80061 | Lipid panel | <1% | 170 | $145.85 |
| 86580 | <1% | 12 | $102.55 | |
| 36415 | Collection of venous blood by venipuncture | <1% | 3,950 | $60.91 |
| G0444 | Annual depression screening, 5 to 15 minutes | <1% | 7,181 | $52.50 |
| 99439 | <1% | 191 | $46.56 | |
| 83014 | <1% | 14 | $46.15 | |
| J0696 | Injection, ceftriaxone sodium, per 250 mg | <1% | 82 | $44.47 |
| 99072 | <1% | 78 | $41.54 | |
| 90633 | <1% | 3,118 | $37.73 | |
| 82948 | <1% | 13 | $30.87 | |
| J1100 | Injection, dexamethasone sodium phosphate, 1 mg | <1% | 99 | $20.84 |
| 96161 | <1% | 51 | $20.63 | |
| 3051F | <1% | 41 | $20.00 | |
| J1885 | Injection, ketorolac tromethamine, per 15 mg | <1% | 13 | $13.41 |
| G0442 | Annual alcohol misuse screening, 5 to 15 minutes | <1% | 4,618 | $10.50 |
| 84436 | <1% | 107 | $7.91 | |
| 1160F | <1% | 7,566 | $7.01 | |
| 90697 | <1% | 54 | $0.07 | |
| 90648 | <1% | 4,094 | $0.03 | |
| 3074F | <1% | 7,579 | $0.01 | |
| G8420 | Bmi is documented within normal parameters and no follow-up plan is required | <1% | 3,602 | $0.01 |
| 1036F | <1% | 3,950 | $0.01 | |
| 3725F | <1% | 8,628 | $0.01 | |
| 1033F | <1% | 6,901 | $0.01 | |
| 1159F | <1% | 7,084 | $0.01 | |
| 90681 | <1% | 358 | $0.01 | |
| 3078F | <1% | 6,124 | $0.01 | |
| 90707 | <1% | 103 | $0.01 | |
| 90696 | 0% | 1,365 | $0.00 | |
| 90680 | 0% | 2,664 | $0.00 | |
| 1126F | 0% | 3,666 | $0.00 | |
| 3079F | 0% | 3,757 | $0.00 | |
| 1034F | 0% | 1,875 | $0.00 | |
| 1000F | 0% | 4,288 | $0.00 | |
| 90698 | 0% | 652 | $0.00 | |
| 1125F | 0% | 2,905 | $0.00 | |
| 1170F | 0% | 1,219 | $0.00 | |
| 3075F | 0% | 2,228 | $0.00 | |
| 3061F | 0% | 28 | $0.00 | |
| 1101F | 0% | 357 | $0.00 | |
| 1111F | 0% | 1,573 | $0.00 | |
| G2058 | Chronic care management services, each additional 20 minutes of clinical staff time directed by a physician or other qualified health care professional, per calendar month (list separately in addition to code for primary procedure). (do not report g2058 for care management services of less than 20 minutes additional to the first 20 minutes of chronic care management services during a calendar month). (use g2058 in conjunction with 99490). (do not report 99490, g2058 in the same calendar month as 99487, 99489, 99491)). | 0% | 50 | $0.00 |
| G8418 | Bmi is documented below normal parameters and a follow-up plan is documented | 0% | 1,103 | $0.00 |
| 90723 | 0% | 2,859 | $0.00 | |
| 96127 | 0% | 220 | $0.00 | |
| 90716 | 0% | 91 | $0.00 | |
| 84480 | 0% | 108 | $0.00 | |
| G9903 | Patient screened for tobacco use and identified as a tobacco non-user | 0% | 28 | $0.00 |
| G9902 | Patient screened for tobacco use and identified as a tobacco user | 0% | 102 | $0.00 |
| 1035F | 0% | 53 | $0.00 | |
| 3008F | 0% | 138 | $0.00 | |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | 0% | 114 | $0.00 |
| G0506 | Comprehensive assessment of and care planning for patients requiring chronic care management services (list separately in addition to primary monthly care management service) | 0% | 16 | $0.00 |
| G9906 | Patient identified as a tobacco user received tobacco cessation intervention during the measurement period or in the six months prior to the measurement period (counseling and/or pharmacotherapy) | 0% | 104 | $0.00 |
| G0008 | Administration of influenza virus vaccine | 0% | 101 | $0.00 |
| 90744 | 0% | 43 | $0.00 | |
| 99441 | 0% | 12 | $0.00 | |
| 4037F | 0% | 44 | $0.00 | |
| 3052F | 0% | 18 | $0.00 | |
| G8427 | Eligible clinician attests to documenting in the medical record they obtained, updated, or reviewed the patient's current medications | 0% | 3,548 | $0.00 |
| 90710 | 0% | 2,850 | $0.00 | |
| G8417 | Bmi is documented above normal parameters and a follow-up plan is documented | 0% | 5,011 | $0.00 |
| 4004F | 0% | 1,152 | $0.00 | |
| G8482 | Influenza immunization administered or previously received | 0% | 106 | $0.00 |
| 1158F | 0% | 2,880 | $0.00 | |
| 90700 | 0% | 1,341 | $0.00 | |
| 1032F | 0% | 1,827 | $0.00 | |
| 3288F | 0% | 1,084 | $0.00 | |
| 90685 | 0% | 176 | $0.00 | |
| 1090F | 0% | 249 | $0.00 | |
| G8783 | Normal blood pressure reading documented, follow-up not required | 0% | 123 | $0.00 |
| 4035F | 0% | 460 | $0.00 | |
| 3077F | 0% | 34 | $0.00 | |
| 1124F | 0% | 13 | $0.00 | |
| 1100F | 0% | 12 | $0.00 | |
| 99453 | 0% | 17 | $0.00 | |
| G0438 | Annual wellness visit; includes a personalized prevention plan of service (pps), initial visit | 0% | 12 | $0.00 |
Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.
From NPPES
Who's on the registration
Authorized officialGOIN, JOSEPH (MEDICAL DIRECTOR)
| Provider | Location | Paid |
|---|---|---|
| Calvary Urgent Care PA | Humble, TX | $744K |
| DR. Goin and Associates | Dayton, TX | $563K |
Matched on the authorized-official name exactly as entered in NPPES. A common name can match unrelated people.